Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Singla reviews the comparative analysis she and colleagues conducted of guidelines for the diagnosis and treatment of psoriatic arthritis and how they differ between the professional societies.
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
Dr Mease continues his review of the findings of the POETYK clinical trials of the TYK 2 inhibitor deucravacitinib, including patient-reported outcomes among patients treated with the therapy.
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In part 1 of a two-part podcast, Dr Mease reviews the findings of two clinical trials of the TYK 2 inhibitor deucravacitinib: POETYK 1 of patients without previous biologic treatment, POETYK 2, which included some patients with exposure to...
In the first of two videos on the impact and treatment of obesity in psoriatic arthritis, Dr Alexis Ogdie reviews recent research on how obesity affects the severity of disease and the effect of weight loss on patients with PsA.
In the first of two videos on the impact and treatment of obesity in psoriatic arthritis, Dr Alexis Ogdie reviews recent research on how obesity affects the severity of disease and the effect of weight loss on patients with PsA.
In part 2 of her video on psoriatic arthritis and obesity, Dr Ogdie reviews recent studies showing how combination therapy with GLP-1 RAs may not only boost weight loss but also help patients achieve minimal disease activity.
In part 2 of her video on psoriatic arthritis and obesity, Dr Ogdie reviews recent studies showing how combination therapy with GLP-1 RAs may not only boost weight loss but also help patients achieve minimal disease activity.
Dr Coates discusses a post-hoc analysis of the FOREMOST study that aimed to identify psoriatic arthritis patients at the highest risk of progressing from fewer than 5 tender or swollen joints to polyarticular disease with much higher counts...
Dr Coates discusses a post-hoc analysis of the FOREMOST study that aimed to identify psoriatic arthritis patients at the highest risk of progressing from fewer than 5 tender or swollen joints to polyarticular disease with much higher counts...
Dr Karmacharya reviews his presentation from ACR Convergence a population-based study from the UK THIN database across psoriatic arthritis, psoriasis, and axial spondyloarthritis to find distinct and remarkably stable patterns of...
Dr Karmacharya reviews his presentation from ACR Convergence a population-based study from the UK THIN database across psoriatic arthritis, psoriasis, and axial spondyloarthritis to find distinct and remarkably stable patterns of...
In a cross-sectional study of 36 isolated nail psoriasis patients, 7 of them (19%) went on to develop psoriatic arthritis in the following years. Is there more to this connection between isolated nail psoriasis and early detection of PsA? Dr...
In a cross-sectional study of 36 isolated nail psoriasis patients, 7 of them (19%) went on to develop psoriatic arthritis in the following years. Is there more to this connection between isolated nail psoriasis and early detection of PsA? Dr...
Rheumatology and Arthritis Learning Network® is an online resource for the latest developments in rheumatology practice, providing a customized experience for readers to stay informed about the topics that matter most to them.